The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Sio Gene Therapies, Inc(NASDAQ:SIOX)


Sio Gene Therapies, Inc., a clinical-stage gene therapy company, focuses on developing various product candidates for debilitating neurodegenerative diseases. The company's clinical-stage programs include AXO-Lenti-PD program for the treatment of Parkinson's disease; AXO-AAV-GM1 program for the trea...
Website: http://www.axovant.com/
Founded: 2014
Full Time Employees: 38
CEO: Pavan Cheruvu
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Sio Gene Therapies Op Cashflow Per Share ttm
Sio Gene Therapies Free Cashflow Per Share ttm
Sio Gene Therapies Cash Per Share ttm
Sio Gene Therapies (GAAP) P/E ratio ttm
Sio Gene Therapies P/B ratio ttm
No extra charts and metrics for this ticker.